Skip to content
DataLookout
Menu

Biossil Inc. clinical trial pipeline

Get alerts when Biossil Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-08

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: RESCUE · SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype Enrollment reduced: 105 → 65 participants Biossil Inc.Phase 2 NCT07282210
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 2
1

Disease areas by active trials

Get alerts when Biossil Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free